학술논문
Adjunctive brexpiprazole 1 mg and 2 mg daily for Japanese patients with major depressive disorder following inadequate response to antidepressants: a phase 2/3, randomized, double-blind (BLESS) study
Document Type
Article
Author
Source
In: Psychiatry and Clinical Neurosciences . (Psychiatry and Clinical Neurosciences, February 2024, 78(2):113-122)
Subject
Language
English
ISSN
14401819
13231316
13231316